| Size | Price | Stock | Qty |
|---|---|---|---|
| 250mg |
|
||
| Other Sizes |
| Targets |
Natural flavonoid in green tea; COX-1/cyclooxygenase-1
|
|---|---|
| ln Vitro |
Catechin, the name of which is derived from catechu of the extract of Acacia catechu L., is 3,3’,4’,5,7-pentahydroxyflavan with two steric forms of (+)-catechin (Figure 1) and its enantiomer. In addition, in a broad sense, catechin represents the chemical family name of the compounds derived from catechin. Catechins are distributed in a variety of foods and herbs including tea, apples, persimmons, cacaos, grapes, and berries. This special issue is devoted to information on catechin’s activities related to human health[1].
|
| References | |
| Additional Infomation |
(+)-Catechin is the (+)-enantiomer of catechin and is a polyphenolic antioxidant plant metabolite. It has dual functions of antioxidation and plant metabolism. It is the enantiomer of (-)-catechin. An antioxidant flavonoid compound, mainly found in woody plants, exists in both (+)-catechin and (-)-epicatechin (cis) forms. It has been reported that anthocyanin alcohols are found in tea (Camellia sinensis), peony (Paeonia obovata), and other organisms with relevant data. Catechins are metabolites found or produced in Saccharomyces cerevisiae. An antioxidant flavonoid compound, mainly found in woody plants, exists in both (+)-catechin and (-)-epicatechin (cis) forms. See also: gallic catechin (with subclasses); Kroefeller (monomer). Blueberry (partial)...
Tea, a product made from the leaves and buds of the tea plant (Camellia sinensis), is one of the richest sources of catechins, with its main catechin component being (−)-epigallocatechin-3-gallate (EGCG) (Figure 1). EGCG has numerous health benefits, such as anti-cancer, anti-obesity, anti-diabetic, anti-cardiovascular disease, anti-infection, hepatoprotective, and neuroprotective effects. Numerous human epidemiological and clinical studies on tea have confirmed its anti-cancer efficacy, supported by cell and animal experiments, although some studies have reported conflicting results. Furthermore, detailed molecular mechanisms of action of EGCG and other catechins have been proposed. One of the most intriguing mechanisms involves reactive oxygen species (ROS). EGCG is known to have a dual role with respect to ROS, acting as both an antioxidant and a pro-oxidant. Multiple pieces of evidence suggest that EGCG can both eliminate ROS by scavenging them and promote their production. Regarding the anticancer effects of green tea catechins, Shirakami and Shimizu provided updated information on their various mechanisms, including antioxidant, pro-oxidative and anti-inflammatory activities, immune and epigenetic modifications, and receptor tyrosine kinase inhibition. They noted that due to the low bioavailability of EGCG, it is currently unclear whether observations of high concentrations of EGCG in vitro can be directly extrapolated to cancer chemoprevention in animals and humans. [1] |
| Molecular Formula |
C15H14O6
|
|---|---|
| Molecular Weight |
290.26806
|
| Exact Mass |
308.089
|
| CAS # |
7295-85-4
|
| Related CAS # |
(+)-Catechin hydrate;225937-10-0;Catechin;154-23-4
|
| PubChem CID |
9064
|
| Appearance |
White to off-white solid powder
|
| Melting Point |
214 °C
|
| LogP |
1.481
|
| Hydrogen Bond Donor Count |
5
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
1
|
| Heavy Atom Count |
21
|
| Complexity |
364
|
| Defined Atom Stereocenter Count |
2
|
| SMILES |
C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O
|
| InChi Key |
PFTAWBLQPZVEMU-DZGCQCFKSA-N
|
| InChi Code |
InChI=1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15+/m0/s1
|
| Chemical Name |
(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol
|
| Synonyms |
2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol; L-Epicatechin; 13392-26-2; 7295-85-4; (+/-)-Catechin; (+/-)-Epicatechin; 17334-50-8; CHEBI:23053;
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~125 mg/mL (~430.63 mM)
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.4451 mL | 17.2253 mL | 34.4507 mL | |
| 5 mM | 0.6890 mL | 3.4451 mL | 6.8901 mL | |
| 10 mM | 0.3445 mL | 1.7225 mL | 3.4451 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.